Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

Clinical trial NCT00976508 · TERMINATED

Trial details

NCT number: NCT00976508
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Neoplasms Lung Neoplasms Breast Neoplasms Prostatic Neoplasms Sarcoma

Start date: 2009-11-01
Primary completion: 2011-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.